Seqster Launches MyAlzheimer's Patient Registry
Tool targets advanced drug monitoring and safety—and enables access to real-world data.
Seqster PDM, a healthcare technology company, has officially launched MyAlzheimer's Patient Registry, which allows patients and caregivers to manage their health data, access new treatment options, and participate in clinical trials in a secure and centralized registry. The platform also enables researchers to access real-world patient data to aid in developing new treatments and gain a deeper understanding of Alzheimer's disease.
MyAlzheimer's features the ability for patients to grant consent for their data to be used for research purposes, including participation in clinical trials. Caregivers can use the registry to coordinate care and manage medication schedules.
MyAlzheimer's Patient Registry is built on the Seqster operating system, connected to over 5,000 healthcare systems and 150,000 healthcare provider sources.
Reference: Seqster Launches MyAlzheimer's Patient Registry for Advanced Drug Monitoring & Safety, May 9, 2023, San Diego, CA.
Telemedicine Considerations When Conducting Decentralized Clinical Trials
January 14th 2025Compliance with state telemedicine requirements is imperative, as not only will most clinical trial sponsors contractually require such compliance, but non-compliance may also subject the practitioner to licensure violations and liability.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
